Hemocompatibility of folic-acid-conjugated amphiphilic PEG-PLGA copolymer nanoparticles for co-delivery of cisplatin and paclitaxel: treatment effects for non-small-cell lung cancer-Reference-Cited by-同舟云学术

Hemocompatibility of folic-acid-conjugated amphiphilic PEG-PLGA copolymer nanoparticles for co-delivery of cisplatin and paclitaxel: treatment effects for non-small-cell lung cancer

Published:2015-12-22 Issue:6 Volume:37 Page:7809-7821
ISSN:1010-4283
Container-title:Tumor Biology
language:en
Short-container-title:Tumor Biol.

Author:

He Zelai,Shi Zengfang,Sun Wenjie,Ma Jing,Xia Junyong,Zhang Xiangyu,Chen Wenjun,Huang Jingwen

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13277-015-4634-1.pdf

Reference40 articles.

1. Quoix E, Zalcman G, Oster JP, Westeel V, Pichon E, Lavolé A, et al. Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial. Lancet. 2011;378(9796):1079–88.

2. Morton SW, Lee MJ, Deng ZJ, Dreaden EC, Siouve E, Shopsowitz KE, et al. A nanoparticle-based combination chemotherapy delivery system for enhanced tumor killing by dynamic rewiring of signaling pathways. Sci Signal. 2014;7(325):ra44.

3. Duncan R. Polymer conjugates as anticancer nanomedicines. Nat Rev Cancer. 2006;6(9):688–701.

4. Ding L, Liu K, Jiang Z, Chen Q, Zhou N, Liang Y, et al. The efficacy and safety of pemetrexed plus bevacizumab in previously treated patients with advanced non-squamous non-small cell lung cancer (ns-NSCLC). Tumour Biol. 2015;36(4):2491–9.

5. Hu CM, Zhang L. Nanoparticle-based combination therapy toward overcoming drug resistance in cancer. Biochem Pharmacol. 2012;83(8):1104–11.

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanotoxicological profiles of clinically approved nanoplatforms;Beni-Suef University Journal of Basic and Applied Sciences;2023-12-16

2. Role of Copolymers in Lung Cancer;Block Co-polymeric Nanocarriers: Design, Concept, and Therapeutic Applications;2023

3. Targeted therapy of non-small cell lung cancer and liver cancer: functional nanocarriers for the delivery of cisplatin and tissue factor pathway inhibitor-2;Chemotherapy;2022-11-03

4. Recent Innovations in the Strategies for the Functionalization of Chitosan, Pectin, Alginate, Hyaluronic Acid, Dextran and Inulin Biomaterials for Anticancer Applications-A Review;Journal of Polymers and the Environment;2022-10-29

5. Advanced cisplatin nanoformulations as targeted drug delivery platforms for lung carcinoma treatment: a review;Journal of Materials Science;2022-09